Serum Fetuin-A, Cardiovascular Risk Factors, and Six-Year Follow-up Outcome in Patients With Coronary Heart Disease
- 1 June 2010
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 105 (12) , 1666-1672
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Plasma Fetuin-A Levels and the Risk of Myocardial Infarction and Ischemic StrokeCirculation, 2008
- Fetuin-A and Incident Diabetes Mellitus in Older PersonsJAMA, 2008
- Atherogenic dyslipidaemia but not total- and high-molecular weight adiponectin are associated with the prognostic outcome in patients with coronary heart diseaseEuropean Heart Journal, 2007
- Fetuin-A Is an Independent Predictor of Death after ST-Elevation Myocardial InfarctionClinical Chemistry, 2007
- Comparison of N-Terminal Pro–B-Natriuretic Peptide, C-Reactive Protein, and Creatinine Clearance for Prognosis in Patients With Known Coronary Heart DiseaseArchives of internal medicine (1960), 2006
- Myocardial Stiffness, Cardiac Remodeling, and Diastolic Dysfunction in Calcification-Prone Fetuin-A–Deficient MiceJournal of the American Society of Nephrology, 2005
- Serum fetuin-A in nondialyzed patients with diabetic nephropathy: Relationship with coronary artery calcificationKidney International, 2005
- Short-term benefit of smoking cessation in patients with coronary heart disease: estimates based on self-reported smoking data and serum cotinine measurementsEuropean Heart Journal, 2004
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Serum concentration of human alpha 2 HS glycoprotein during the inflammatory process: evidence that alpha 2 HS glycoprotein is a negative acute-phase reactant.Journal of Clinical Investigation, 1979